(Photo : JTBC Official Instagram)
Korean drama Law School commenced with a good viewership rating and showed a positive response.
The JTBC s new drama, which replaced the post-apocalyptic sci-fi series Sisyphus: the Myth, starring Cho Seung Woo and Park Shin Hye, managed to score 5.1 percent for its nationwide rating and 5.7 percent in the metropolitan area, as cited by Nielsen Korea.
Meanwhile, its competitor, KBS2 s Daebak Real Estate, which also premiered on the same date, reached 4.1 percent and 5.3 percent of national ratings.
#LawSchoolEp1 Trends on Twitter
Despite being compared with the US series How to Get Away with Murder, viewers also expressed their support for the mystery crime series as #LawSchoolEp1 trends on Twitter alongside good feedback from the audience.
South Korea to expand COVID-19 vaccine drive, aims to inoculate a quarter of population by June
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
About 1% of population vaccinated in Korea
koreatimes.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreatimes.co.kr Daily Mail and Mail on Sunday newspapers.
South Korean hospitals extract extra COVID-19 vaccine doses from vials Toggle share menu
Advertisement
South Korean hospitals extract extra COVID-19 vaccine doses from vials
A nurse fills a syringe with the Pfizer BioNTech vaccine Covid-19 at the National Medical Center vaccination center in Seoul, South Korea February 27, 2021. Song Kyung-Seok/Pool via REUTERS
10 Mar 2021 05:32PM Share this content
Bookmark
SEOUL: In a handful of South Korean hospitals, designated nurses are using specially designed syringes to squeeze extra doses of coronavirus vaccine out of each vial in a bid to stretch the still limited number of vials to cover more people.
The practice has raised debate over medical safety and commercial concerns from the manufacturers who charge by the dose.